glp-1 gip news 🚨 Big for people with type 1 diabetes who are using or are interested in using a GLP-1! 35 new recommendations have been published for use of GLP-1s and GLP-1/GIP in Beyond the pancreas: contrasting cardiometabolic

FGF19, FGF21, and an FGFR1/-Klotho-activating antibody act on the nervous system to regulate body weight and glycemia

For weight management, the Food and Drug Administration (FDA) has approved two medications: Semaglutide (Wegovy) Tirzepatide (Zepbound) These drugs contain the same active ingredients as diabetes medications such as Ozempic and Mounjaro, but Wegovy and Zepbound are specifically approved for chronic weight management

: :

But it creates a specific nutrition problem

News Release July 10, 2009 Nine joint health supplements fail ConsumerLab.com quality review -- Lead contamination, missing ingredients and other problems found in supplements for people as well as for dogs, cats and horses

[4] A more potent, binding-protein-resistant analog such as IGF-1 LR3 would, by mechanism, be expected to retain this hypoglycemic potential, and because it evades the buffering system that normally tempers free IGF-1 activity, the metabolic effect could in principle be less predictable